The effect of uriculotherapy on pain after cesarean sectio
Not Applicable
Recruiting
- Conditions
- Pain after cesarean section.Other acute postprocedural painG89.18
- Registration Number
- IRCT20130822014436N1
- Lead Sponsor
- Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 66
Inclusion Criteria
Previous history of cesarean section,
Gestational age 37-40 weeks
age 18-35 years
Similar anesthesia protocol
Exclusion Criteria
History of diabetes
High blood pressure
Kidney, liver and cardiovascular diseases, neurological diseases
Consumption of any medicine, cigarettes, alcohol
Vaginal delivery history
History of ear disease treatment during the last six months
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visual Analogue Scale(VAS). Timepoint: Pain intensity will be measured and recorded at times (15-30-60 minutes) and (3-6-12-24 hours) after the intervention. Method of measurement: the patient is the Visual Adjustment Scale (VAS).
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie auriculotherapy's analgesic effects in postcesarean pain management?
How does auriculotherapy compare to standard analgesics like NSAIDs or opioids in reducing postoperative pain after cesarean section?
Are there specific biomarkers that predict individual response to auriculotherapy for acute postprocedural pain (G89.18)?
What adverse events are associated with auriculotherapy in postpartum women and how are they managed?
What combination therapies or alternative approaches are being explored alongside auriculotherapy for postcesarean pain relief?